Isabella Martire Md

CLIA Laboratory Citation Details

4
Total Citations
23
Total Deficiencyies
12
Unique D-Tags
CMS Certification Number 21D0915945
Address 8343 Cherry Lane, Laurel, MD, 20707
City Laurel
State MD
Zip Code20707
Phone301 498-5067
Lab DirectorISABELLA MD

Citation History (4 surveys)

Survey - May 16, 2024

Survey Type: Standard

Survey Event ID: 5FRQ11

Deficiency Tags: D5211

Summary:

Summary Statement of Deficiencies D5211 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(a) The laboratory must review and evaluate the results obtained on proficiency testing performed as specified in subpart H of this part. This STANDARD is not met as evidenced by: Based on review of hematology proficiency testing records, and interview with staff, the laboratory did not have the proficiency test providers report showing the scores for each test result reported for each individual unknown sample tested. Findings: 1. For each proficiency test event, the provider sends the laboratory five unknown samples, and there are three events each year. The laboratory submits the results to the proficiency test provider to be evaluated. The proficiency test provider reports the scores to the laboratory for each test result that was reported and also an overall score for the laboratorys performance in hematology. 2. The laboratory obtained and reviewed the providers overall test score for the discipline of hematology, but did did not have the providers evaluation of each test result that was reported to the provider for events two and three of 2023. 3. These findings were confirmed during interview with staff on 4/24/24 at 12:00 pm. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 15, 2022

Survey Type: Standard

Survey Event ID: PQZH11

Deficiency Tags: D3011 D5403 D5403 D5791 D5791

Summary:

Summary Statement of Deficiencies D3011 FACILITIES CFR(s): 493.1101(d) Safety procedures must be established, accessible, and observed to ensure protection from physical, chemical, biochemical, and electrical hazards, and biohazardous materials. This STANDARD is not met as evidenced by: Based on observation of the laboratory testing area and interview with the office manager (OM), the laboratory failed to provide an eyewash station within the work area. Findings: 1. OSHA regulation 29 CFR 1910.151(c) requires that "where the eyes or body of any person may be exposed to injurious corrosive materials, suitable facilities for quick drenching or flushing of the eyes and body shall be provided within the work area for immediate emergency use." 2. The area where the laboratory was performing hematology testing was toured during the survey and no eyewash station was observed. 3. During the survey on 09/15/2022 at 11:15 AM, the OM confirmed that there is no eyewash station within the laboratory where testing is performed. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - March 17, 2021

Survey Type: Standard

Survey Event ID: O92G11

Deficiency Tags: D5791 D6029 D6029 D5209 D5791

Summary:

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on remote record review and phone interview with the office manager and laboratory director (LD), the laboratory did not establish written policies and procedures for assessing the testing personnel as defined in subpart M- CFR 493.1413 (b)(8) through (9): Findings: 1. The laboratory's written procedure manual did not include all the required elements for evaluating the competency of the testing personnel and assuring that they maintain their competency to perform test procedures and report test results promptly, accurately and proficiently. The procedures for evaluation of the competency of the staff must include, but are not limited to: direct observations of routine patient test performance, including patient preparation, if applicable, specimen handling, processing and testing; monitoring the recording and reporting of test results; review of intermediate test results or worksheets, quality control records, proficiency testing results, and preventive maintenance records; direct observation of performance of instrument maintenance and function checks; assessment of test performance through testing previously analyzed specimens, internal blind testing samples or external proficiency testing samples; and assessment of problem solving skills; and evaluating and documenting the performance of individuals responsible for moderate complexity testing at least semiannually during the first year the individual tests patient specimens. 2. Evaluations must be performed at six months and annually thereafter unless test methodology or instrumentation changes, in which case, prior to reporting patient test results, the individual's performance must be reevaluated to include the use of the new test methodology or instrumentation. 3. During the remote survey phone interview on 03/17/2021 at 3:00 Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- PM, the LD confirmed that the policies and procedure manual did not include a written training program along with worksheets for the documentation of the of the training of the testing personnel who perform laboratory testing. D5791 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(a)(c) (a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in 493.1251 through 493.1283. (c) The laboratory must document all analytic systems assessment activities. This STANDARD is not met as evidenced by: Based on remote review of quality control (QC) and monthly quality assurance (QA) records and phone interview with the office manager and laboratory director (LD), the laboratory's QA plan did not include a mechanism to monitor, evaluate and assess the QC results for shifts and trends. Findings: 1. The QC results are printed each day of testing and reviewed to ensure they are within acceptable limits. 2. The QC section on the monthly QA worksheet confirms that temperatures are taken and recorded, reagents and controls have not exceeded their expiration date, instrument maintenance was performed and documented, and remedial action was performed and documented. 3. The review of the QC results did not include a review of the results in a monthly chart or graph so that shifts and trends could be viewed and remedial action taken when needed. 4. During the remote survey phone interview on 03/17/2021 at 3:00 PM, the LD confirmed that the QC results were not evaluated for shifts and trends on a monthly basis. D6029 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(11) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(11) Ensure that prior to testing patients' specimens, all personnel have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. This STANDARD is not met as evidenced by: Based on remote review of testing personal qualifications and competency evaluations and phone interview with the office manager and laboratory director (LD), the LD did not ensure that the testing person (TP) working in the lab met the minimum educational requirements. Findings: 1. The educational documentation submitted for the only TP was not from the United States. Individuals who have degrees from foreign institutions must have an evaluation of their credentials to determine the equivalency of their education to an education obtained in the United States (U.S.). 2. During the remote survey phone interview on 03/17/2021 at 3:00 PM, the LD confirmed that the credential of the TP had not been evaluated to ensure that they met the minimum requirements of a High School diploma to be employed as a TP. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - August 20, 2018

Survey Type: Standard

Survey Event ID: XKU311

Deficiency Tags: D5411 D5421 D5783 D5787 D6005 D6031 D5411 D5421 D5783 D5787 D6005 D6031

Summary:

Summary Statement of Deficiencies D5411 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(a) Test systems must be selected by the laboratory. The testing must be performed following the manufacturer's instructions and in a manner that provides test results within the laboratory's stated performance specifications for each test system as determined under 493.1253. This STANDARD is not met as evidenced by: Based on record review and interview, the lab did not perform calibration of the hematology analyzer as required by the manufacturer. Findings: 1. The lab did not have a record of the calibration check performed in the beginning months of 2018 to meet the manufacturers six month calibration requirement, the previous calibration was performed July 10, 2017 and the next calibration was due in February of 2018; and 2. When interviewed in the afternoon on the day of the survey, lab staff stated that the calibration records for February 2018 were not available. D5421 ESTABLISHMENT AND VERIFICATION OF PERFORMANCE CFR(s): 493.1253(b)(1) Each laboratory that introduces an unmodified, FDA-cleared or approved test system must do the following before reporting patient test results: (1)(i) Demonstrate that it can obtain performance specifications comparable to those established by the manufacturer for the following performance characteristics: (1)(i)(A) Accuracy. (1)(i) (B) Precision. (1)(i)(C) Reportable range of test results for the test system. (1)(ii) Verify that the manufacturer's reference intervals (normal values) are appropriate for the laboratory's patient population. This STANDARD is not met as evidenced by: Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 4 -- Based on record review and interview, the lab did not establish the reportable range of the hematology analyzer and verify that the patient normal (reference) ranges are appropriate for the labs patient population. Findings: 1. The laboratory performed validation studies on the hematology analyzer in 2017; 2. The validation did not include data showing that the reportable range of the hematology analyzer and the patient normal ranges were established and verified; and 2. This was confirmed during interview with lab staff on the day of survey. D5783

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access